2 chapters across the catalog
The potential financial burden of 65 million Medicare recipients accessing expensive GLP-1 drugs is estimated to reach hundreds of billions of dollars annually. Concerns are raised that these costs will bankrupt the healthcare system, especially following Oprah Winfrey's recent television special promoting the medications.
A claim is presented from an insurance industry source stating that the lifetime value of a single individual undergoing a full transgender medical transition is worth approximately $7 million to the medical and pharmaceutical communities. Documentation for this specific figure is requested for further verification.
